Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Dexcom Inc (DXCM)

Dexcom Inc (DXCM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 33,915,364
  • Shares Outstanding, K 390,595
  • Annual Sales, $ 3,622 M
  • Annual Income, $ 541,500 K
  • EBIT $ 623 M
  • EBITDA $ 809 M
  • 60-Month Beta 1.12
  • Price/Sales 9.12
  • Price/Cash Flow 42.34
  • Price/Book 17.29

Options Overview Details

View History
  • Implied Volatility 47.54% ( -0.03%)
  • Historical Volatility 32.89%
  • IV Percentile 77%
  • IV Rank 39.86%
  • IV High 78.36% on 10/09/24
  • IV Low 27.12% on 05/16/24
  • Put/Call Vol Ratio 0.93
  • Today's Volume 3,744
  • Volume Avg (30-Day) 8,081
  • Put/Call OI Ratio 0.84
  • Today's Open Interest 112,553
  • Open Int (30-Day) 144,522

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 22 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 0.50
  • Number of Estimates 11
  • High Estimate 0.56
  • Low Estimate 0.41
  • Prior Year 0.50
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
73.62 +17.94%
on 01/13/25
89.59 -3.08%
on 01/27/25
+9.06 (+11.65%)
since 12/31/24
3-Month
67.69 +28.27%
on 11/07/24
89.59 -3.08%
on 01/27/25
+16.35 (+23.20%)
since 10/31/24
52-Week
62.34 +39.28%
on 07/26/24
142.00 -38.85%
on 03/26/24
-33.96 (-28.11%)
since 01/30/24

Most Recent Stories

More News
What to Expect From DexCom's Q4 2024 Earnings Report

DexCom is gearing up to release its fourth-quarter earnings next month, and analysts forecast single-digit profit growth.

XLV : 146.87 (-0.32%)
$SPX : 6,040.53 (-0.50%)
DXCM : 86.83 (-0.90%)
Weakness in Big Tech Drags Stocks Lower

The S&P 500 Index ($SPX ) (SPY ) Thursday closed down -0.21%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.16%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.69%. March E-mini...

GOOGL : 204.02 (+1.57%)
AMAT : 180.35 (-0.75%)
LTH : 28.99 (-2.52%)
AAPL : 236.00 (-0.67%)
PNC : 200.95 (-0.55%)
DDOG : 142.71 (+0.07%)
TXN : 184.61 (-0.36%)
$IUXX : 21,478.05 (-0.14%)
UNH : 542.49 (-0.56%)
ELV : 395.70 (-0.91%)
ASML : 739.31 (+0.31%)
ZNH25 : 109-050 (+0.29%)
Stocks Slightly Higher on Chip Stock Strength and Lower T-Note Yields

The S&P 500 Index ($SPX ) (SPY ) today is up +0.12%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.09%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.15%. March E-mini S&P futures (ESH25...

AMAT : 180.35 (-0.75%)
LTH : 28.99 (-2.52%)
PNC : 200.95 (-0.55%)
DDOG : 142.71 (+0.07%)
TXN : 184.61 (-0.36%)
$IUXX : 21,478.05 (-0.14%)
UNH : 542.49 (-0.56%)
ELV : 395.70 (-0.91%)
ASML : 739.31 (+0.31%)
ZNH25 : 109-050 (+0.29%)
MNDY : 255.46 (+5.62%)
ESH25 : 5,942.25 (-2.06%)
Stocks Slightly Lower on Mixed Economic News and Higher Bond Yields

The S&P 500 Index ($SPX ) (SPY ) today is down -0.02%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.26%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.13%. March E-mini S&P futures...

AMAT : 180.35 (-0.75%)
LTH : 28.99 (-2.52%)
AVGO : 221.27 (+2.60%)
PNC : 200.95 (-0.55%)
DDOG : 142.71 (+0.07%)
TXN : 184.61 (-0.36%)
$IUXX : 21,478.05 (-0.14%)
UNH : 542.49 (-0.56%)
ELV : 395.70 (-0.91%)
ASML : 739.31 (+0.31%)
ZNH25 : 109-050 (+0.29%)
MNDY : 255.46 (+5.62%)
2 Healthcare Stocks to Buy Hand Over Fist in January

Stocks tend to perform well in January, but that's not a good reason to invest this month. Strong returns aren't made in a single 30-day period. Instead, as long-term investors know, the key is to hold...

EXAS : 56.05 (+0.04%)
DXCM : 86.83 (-0.90%)
Abbott Stock Trades at a Discounted P/B Value: To Buy or Not to Buy?

Abbott Laboratories ABT shares are trading at a discount to the Zacks Medical Products industry. Its trailing 12-month price-to-book value of 4.91X is significantly lower than the industry average of 7.64X...

ABT : 127.93 (-0.68%)
SYK : 391.29 (+0.22%)
BSX : 102.36 (-0.66%)
DXCM : 86.83 (-0.90%)
3 Beaten-Down Stocks That May Be Due for Big Comebacks in 2025

The past year was a great one for the stock market as a whole, but there were plenty of companies that didn't do well in 2024. Shares of Celsius Holdings (NASDAQ: CELH), DexCom (NASDAQ: DXCM) , and Nike...

CELH : 24.98 (-3.10%)
NKE : 76.90 (-1.83%)
PEP : 150.69 (-0.80%)
DXCM : 86.83 (-0.90%)
These Were the 5 Worst-Performing Stocks in the Nasdaq-100 in 2024

Now that we've shut the door on 2024, it's useful to look back at some of the best -- and, on the flip side, some of the worst -- performers of the year on the stock market. Many outliers were in the tech...

INTC : 19.43 (-2.90%)
MCHP : 54.30 (-1.56%)
MDB : 273.32 (+0.83%)
DXCM : 86.83 (-0.90%)
BIIB : 143.93 (-1.57%)
Zacks Investment Ideas feature highlights: DexCom and Albemarle

For Immediate ReleaseChicago, IL – December 23, 2024 – Today, Zacks Investment Ideas feature highlights DexCom, Inc. DXCM and Albemarle Corporation ALB.2025 Picks: 2 Stocks to Buy Now for 50% UpsideThe...

ALB : 84.19 (-1.70%)
DXCM : 86.83 (-0.90%)
1 Reason to Sell DexCom Stock, and 1 Reason to Buy

Shares of the medical-device maker DexCom (NASDAQ: DXCM) are down by 37% this year. The diabetes-focused healthcare company disappointed investors with its second-quarter results, leading to a massive...

DXCM : 86.83 (-0.90%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakening short term outlook on maintaining the current direction.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of...

See More

Key Turning Points

3rd Resistance Point 89.58
2nd Resistance Point 88.94
1st Resistance Point 87.88
Last Price 86.83
1st Support Level 86.18
2nd Support Level 85.54
3rd Support Level 84.48

See More

52-Week High 142.00
Fibonacci 61.8% 111.57
Fibonacci 50% 102.17
Fibonacci 38.2% 92.77
Last Price 86.83
52-Week Low 62.34

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar